LAWSUITS NEWS & LEGAL INFORMATION
Search Results for
Sort by relevance 1,864 pages found matching %3Cscript%3Ealert%28%27What_Security?%27%29%3C/script%3E- Fentanyl Deaths - Severe Math Problems at FDA
Mar-27-06 Describing fentanyl as a "very strong narcotic," on July 15, 2005, the FDA issued a Public Health Advisory regarding the safe use of transdermal fentanyl patches in response to reports of 120 deaths in patients using the patch for pain management, stating that some patients and doctors might not be fully aware of its dangers. A cursory investigation of dr... - Legal ADHD Speed - Becoming Drug Of Choice For Americans
Mar-21-06 A study published online in the February 2006, Journal of Drug and Alcohol Dependence, that examined data from a 2002 survey of about 67,000 households, estimates that more than 7 million Americans have misused stimulant drugs meant to treat ADHD, and "substantial numbers of teenagers and young adults appear to show signs of addiction, according to a compreh... - California Overtime benefits Employers
Mar-20-06 Terri Reese from Vista, California was classified as an exempt manager. Her contract stated that she wouldn't perform the duties of hourly employees except in an emergency. As it turned out, every day was an emergency. She was hired to manage the mess hall for the Marine Corps base at Camp Pendleton. Because Reese wasn't paid hourly, she wasn't paid overt... - Tequin - Blood-Sugar Problems Ain't All
Mar-17-06 The antibiotic, Tequin, manufactured by Bristol Myers Squibb, has been linked to both hypoglycemia and hyperglycemia by researchers who examined treatment outcomes associated with various antibiotics in approximately 1.4 million patients, 66 years of age and older, between April 2002 and March 2004. A team of Canadian scientists from the Institute of Clin... - ADHD Experts Head to Washington - Is the FDA up to the Task?
Mar-14-06 Heavy-hitters from across the country are heading to Washington this month to debate representatives of the pharmaceutical industry during FDA hearings on the controversy surrounding the over-prescribing of attention deficit drugs to children. The International Center for the Study of Psychiatry and Psychology (ICSPP) will be represented by five of the le... - Pfizer Makes List of Worst Corporate Evildoers
Mar-13-06 On January 3, 2006 the Global Exchange Report named the top fourteen "Worst Corporate Evildoers" in the world for 2005. Pfizer, one of the most profitable drug companies on earth, with sales over $52 billion in 2004, made the list of Evildoers. Pfizer's participation in the cover-up of the deadly side effects of Bextra surely contributed to its membership... - Life After Depo-Medrol - Sheer Hopeless Hell
Mar-10-06 Complaining of a sudden localized hip pain, in January 2002, Dennis Capolongo, was diagnosed with a disc herniation and given 2 epidural injections of the steroid Depo-Medrol that resulted in two trips to the ER, a stint in the hospital, and horrific back pain that continued nonstop for months. A short time later, when reviewing his original MRIs, new doc... - Genentech and Biogen Legal Troubles - When It Rains It Pours
Mar-7-06 Rituxan gained FDA approval in 1997, as a treatment for a certain type of non-Hodgkin's lymphoma. Roughly 12,760 patients in the US have the form of cancer Rituxan was approved to treat. Yet by 2005, sales of the drug grew to $1.8 billion in the US. A lawsuit filed by a former Rituxan salesman explains how this happened. On January 11, 2006, Dow Jones r... - Tysabri Clinical Trial - Woman Misdiagnosed With MS Dies
Mar-1-06 It's always about money. Despite an annual cost of $23,500, initial sales of Tysabri were booming. As a once-a-month drug administered by a doctor, it received fast-track approval in late 2004. When it was withdrawn from the market 3 months later, 5,000 patients were on it and 15,000 more were awaiting insurance verification for the first dose. Biogen Ide... - FDA Grants Guinea Pig Status To US Citizens
Feb-28-06 "It is outrageous that, for all intents and purposes, the FDA allowed a clinical trial to proceed, which makes every citizen in the United States a potential "guinea pig," without providing a practical, informative warning to the public." The statement of outrage above was included in a letter to acting FDA Commissioner, Dr von Eschenbach, from Senator Ch... - FDA Shields Drug Companies From Lawsuits
Feb-27-06 Last month, the FDA revealed its latest protective policy for drug companies in a statement that said people who believe they have been injured by drugs approved by the FDA should not be allowed to sue drug companies in state courts. "We think that if your company complies with the FDA processes, if you bring forward the benefits and risks of your drug, a... - Adderall Online - Black Market Profits In Plain Sight
Feb-24-06 Dubbed "Kiddie Coke," Adderall is being abused by increasing numbers of high school and college students all across America. It's difficult to quantify the extent of the abuse among students due the availability of the drug through legal prescriptions and on the internet. Adderall is an amphetamine, a class of stimulant drugs that were widely abused wh... - AOL and Compuserve Telephone Cramming
Feb-21-06 AOL can't get its billing act together: Customers are still complaining of double billing and over-billing. You would think a high-tech Internet service provider like AOL would be able to get the little things - like account billing - right. Despite being a deep-pocketed, multi-media, premier Internet service provider, (with years of complaints and lawsu... - Zyprexa Medicaid Gravy Train Derailed
Feb-20-06 When Zyprexa was approved to treat adults with schizophrenia in 1996, Eli Lilly and the FDA knew about the drug's lethal side effects. Data from a 1996 six-week clinical trial revealed 27 deaths, 15 of which were suicides, and a drop-out rate of 65%. In his book, Mad In America, investigative journalist Robert Whitaker, reported that one in every 145... - Strattera - 130 Reports Of Suicidality In One Month
Feb-15-06 A not yet released discussion paper written by the British Medicines and Healthcare Regulatory Agency, reveals that last fall, there were 130 reports of suicidality in a single month by patients treated with the attention deficit drug Strattera. In addition, the paper reveals that there have also been more than 760 spontaneous reports of cardiac disorders... - ADHD Drugs - Cash Cow For Pharma
Feb-13-06 "Our society viewed with loathing those who 'pushed' stimulant drugs on children," says child psychiatrist Dr Peter Breggin. "Yet today, there are more children taking Ritalin and amphetamines from doctors than ever received them from illegal pushers," he says. "Parents and teachers and even doctors have been badly misled by drug company marketing practic... - Ortho Evra: Two Women's Accounts
Feb-3-06 Despite the late warning by the FDA, the patch has not been taken off the market! Will more women suffer the agony of blood clots like Maria Urenda and Hillary Burris? Why has it taken so long, so many serious injuries and even fatal deaths for the makers of Ortho Evra to warn consumers? Ortho McNeil, a Johnson and Johnson subsidiary, in conjunction... - Vaccinating For Profit - From Cradle to Coffin
Feb-2-06 Due to the flooding of special education classrooms, along with the rising medical costs of treating injured children, local taxes will soon go through the roof, at which time the public will be forced to face the unthinkable truth about the poisoned generation. And when that happens, government officials had better not even think about trying to feign i... - Natrecor Heart Drug - Deadly and Expensive
Jan-31-06 Let there be no mistake, Johnson & Johnson, and its subsidiary Scois, knew all about the dangers associated with its heart failure drug Natrecor, but threw caution to the wind in promoting its off-label use in pursuit of profits. Natrecor was FDA approved in August 2001 for the sole purpose of treating patients for the most acute from of congestive heart... - SJS - Called A Fate Worse Than Death
Jan-29-06 Until Susie Orme developed Stevens Johnson Syndrome, it was a condition she read about in medical textbooks and a difficult topic to study for on her postgraduate exams. Susie is a doctor and as such, she was able to diagnose her own SJS. However, "no amount of training could prepare me for the pain ahead," she said. Susie's SJS was a reaction to the a...